Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Alyce Adams, PhD, tackles 5 questions about the barriers to health care among vulnerable patient populations and her motivation towards finding solutions.
Kaiser Permanente research reveals new insights into variability in glaucoma risk within self-reported race/ethnicity groups.
Kaiser Permanente research provides the best evidence to date on the association between sexual assault, health disorders and healthcare use.
Hospitalized patients who experience acute kidney injury face a 44 percent greater risk of heart failure during their first year after leaving the hospital, according to a new Kaiser Permanente study.
Continuous heart monitoring may help physicians identify patients at higher risk and tailor treatments.
Neurologists of the Kaiser Permanente Northern California Stroke FORCE team get clot-busting alteplase to patients twice as fast as the national average.
Google’s Street View mapping cars have been mapping more than roads lately. Outfitted with new sensors to measure traffic-related air pollution, the cars roamed the streets of Oakland to create a block-by-block map of air pollution in three neighborhoods.
DOR's Theodore (TR) Levin, MD, is one of four recipients of The Permanente Medical Group's 2018 Sidney R. Garfield Exceptional Contribution Awards, for pioneering efforts to expand colorectal cancer screening.
A study of patients' electronic medical records shows that, at the height of its popularity, the smartphone game resulted in injuries similar to those linked with other moderate-intensity outdoor activities.
By analyzing the genomes of people with depression and comparing them with the genomes of people without depression, a global team, including Kaiser Permanente researchers, identified 44 specific places in the human genome with links to depression.